259 related articles for article (PubMed ID: 33803967)
41. Engineered 3D tumour model for study of glioblastoma aggressiveness and drug evaluation on a detachably assembled microfluidic device.
Ma J; Li N; Wang Y; Wang L; Wei W; Shen L; Sun Y; Jiao Y; Chen W; Liu J
Biomed Microdevices; 2018 Sep; 20(3):80. PubMed ID: 30191323
[TBL] [Abstract][Full Text] [Related]
42. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
[TBL] [Abstract][Full Text] [Related]
43. Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?
Hoarau-Véchot J; Rafii A; Touboul C; Pasquier J
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29346265
[TBL] [Abstract][Full Text] [Related]
44. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
[TBL] [Abstract][Full Text] [Related]
45. Cell subtype-dependent formation of breast tumor spheroids and their variable responses to chemotherapeutics within microfluidics-generated 3D microgels with tunable mechanics.
Lee D; Cha C
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110932. PubMed ID: 32409080
[TBL] [Abstract][Full Text] [Related]
46. Impact of the spheroid model complexity on drug response.
Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
[TBL] [Abstract][Full Text] [Related]
47. Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids.
Herrmann R; Fayad W; Schwarz S; Berndtsson M; Linder S
J Biomol Screen; 2008 Jan; 13(1):1-8. PubMed ID: 18040052
[TBL] [Abstract][Full Text] [Related]
48. Establishment of Microfluidic Spheroid Cultures for Biomedical Applications.
Kwapiszewska K
Methods Mol Biol; 2018; 1771():213-224. PubMed ID: 29633216
[TBL] [Abstract][Full Text] [Related]
49. Hydrogel 3D in vitro tumor models for screening cell aggregation mediated drug response.
Monteiro MV; Gaspar VM; Ferreira LP; Mano JF
Biomater Sci; 2020 Mar; 8(7):1855-1864. PubMed ID: 32091033
[TBL] [Abstract][Full Text] [Related]
50. A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy.
Ascheid D; Baumann M; Pinnecker J; Friedrich M; Szi-Marton D; Medved C; Bundalo M; Ortmann V; Öztürk A; Nandigama R; Hemmen K; Ergün S; Zernecke A; Hirth M; Heinze KG; Henke E
Nat Commun; 2024 Apr; 15(1):3599. PubMed ID: 38678014
[TBL] [Abstract][Full Text] [Related]
51. Robotic printing and drug testing of 384-well tumor spheroids.
Ham SL; Thakuri PS; Tavana H
Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():2183-6. PubMed ID: 26736723
[TBL] [Abstract][Full Text] [Related]
52. Spatially gradated hydrogel platform as a 3D engineered tumor microenvironment.
Pedron S; Becka E; Harley BA
Adv Mater; 2015 Mar; 27(9):1567-72. PubMed ID: 25521283
[TBL] [Abstract][Full Text] [Related]
53. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
Daher A; de Groot J
Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
[TBL] [Abstract][Full Text] [Related]
54. A rapid high throughput bioprinted colorectal cancer spheroid platform for
Johnson PA; Menegatti S; Chambers AC; Alibhai D; Collard TJ; Williams AC; Bayley H; Perriman AW
Biofabrication; 2022 Nov; 15(1):. PubMed ID: 36321254
[TBL] [Abstract][Full Text] [Related]
55. Patterning hypoxic multicellular spheroids in a 3D matrix - a promising method for anti-tumor drug screening.
Ma J; Zhang X; Liu Y; Yu H; Liu L; Shi Y; Li Y; Qin J
Biotechnol J; 2016 Jan; 11(1):127-34. PubMed ID: 26647062
[TBL] [Abstract][Full Text] [Related]
56. The production of 3D tumor spheroids for cancer drug discovery.
Sant S; Johnston PA
Drug Discov Today Technol; 2017 Mar; 23():27-36. PubMed ID: 28647083
[TBL] [Abstract][Full Text] [Related]
57. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
Wang C; Tong X; Yang F
Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
[TBL] [Abstract][Full Text] [Related]
58. Development and characterization of a microfluidic model of the tumour microenvironment.
Ayuso JM; Virumbrales-Muñoz M; Lacueva A; Lanuza PM; Checa-Chavarria E; Botella P; Fernández E; Doblare M; Allison SJ; Phillips RM; Pardo J; Fernandez LJ; Ochoa I
Sci Rep; 2016 Oct; 6():36086. PubMed ID: 27796335
[TBL] [Abstract][Full Text] [Related]
59. Three-Dimensional Aggregated Spheroid Model of Hepatocellular Carcinoma Using a 96-Pillar/Well Plate.
Lee SY; Teng Y; Son M; Ku B; Hwang HJ; Tergaonkar V; Chow PK; Lee DW; Nam DH
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443536
[TBL] [Abstract][Full Text] [Related]
60. Issues with Cancer Spheroid Models in Therapeutic Drug Screening.
Fröhlich E
Curr Pharm Des; 2020; 26(18):2137-2148. PubMed ID: 32067603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
